FDA To Pull Juul E-Cigarettes off US Market
FDA To Pull Juul E-Cigarettes off US Market
FDA To Pull Juul E-Cigarettes , off US Market.
Fox News and other outlets report that the Food and Drug Administration (FDA) is gearing up to order Juul Labs Inc.
To remove its e-cigarettes from store shelves in America.
Fox News and other outlets report that the Food and Drug Administration (FDA) is gearing up to order Juul Labs Inc.
To remove its e-cigarettes from store shelves in America.
The announcement is expected to come as data presented by Juul has been under review for nearly two years.
.
The announcement is expected to come as data presented by Juul has been under review for nearly two years.
.
Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction.
Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction.
Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction.
Critics say underage vaping surged as a result.
Juul has since cut back on its marketing, and in 2019, the company stopped selling fruity, sweet cartridge flavors.
.
Still, sales have dramatically declined for the e-cigarette manufacturer.
.
The sale of all fruity e-cigarette flavors has since been banned by the FDA.
Juul's impending departure would pave the way for Reynolds American Inc.
And NJOY Holidings Inc.
To corner the tobacco-flavored segment of the e-cigarette market.
Juul's impending departure would pave the way for Reynolds American Inc.
And NJOY Holidings Inc.
To corner the tobacco-flavored segment of the e-cigarette market.
Juul's impending departure would pave the way for Reynolds American Inc.
And NJOY Holidings Inc.
To corner the tobacco-flavored segment of the e-cigarette market.
Fox News reports Juul will be able to file an appeal through the FDA, take the matter to court or file a new application with revised products.
.
Fox News reports Juul will be able to file an appeal through the FDA, take the matter to court or file a new application with revised products.